The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...

The U.S. Food and Drug Administration (FDA) approved a novel antipsychotic schizophrenia drug late Thursday, marking the first new treatment in decades for the mental health condition that affects ...

Schizophrenia is estimated to impact approximately 2.8 million people in the U.S. The FDA approval of Cobenfy is supported by data from the EMERGENT clinical program, which includes three placebo ...

The U.S. Food and Drug Administration approved a new schizophrenia treatment on Thursday for the first time in decades, offering an alternative to the antipsychotic medications those with the mental ...

Dupixent is already a blockbuster therapy for a range of immune-mediated diseases, but the Food and Drug Administration’s approval of the ... in development. The FDA decision, announced Friday ...

Sept. 27, 2024 – In a breakthrough for people living with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication ...

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...

The U.S. Food and Drug Administration approved a new schizophrenia treatment on Thursday for the first time in decades, offering an alternative to the antipsychotic medications those with the ...

The U.S. Food and Drug Administration (FDA) announced on Thursday, Sept. 12, that it has authorized “the first over-the-counter hearing aid software device” for individuals with “mild to moderate” ...

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.